These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2146242)

  • 41. Chancroid. Recent advances in treatment and control.
    Ronald AR
    Int J Dermatol; 1986; 25(1):31-3. PubMed ID: 3485081
    [No Abstract]   [Full Text] [Related]  

  • 42. 2017 European guideline for the management of chancroid.
    Lautenschlager S; Kemp M; Christensen JJ; Mayans MV; Moi H
    Int J STD AIDS; 2017 Mar; 28(4):324-329. PubMed ID: 28081686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Susceptibility of Haemophilus ducreyi to spectinomycin in vitro.
    Hafiz S; Jones BM; Kinghorn GR; Duerden BI
    Genitourin Med; 1986 Aug; 62(4):251-2. PubMed ID: 2942458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-dose ceftriaxone for chancroid.
    Bowmer MI; Nsanze H; D'Costa LJ; Dylewski J; Fransen L; Piot P; Ronald AR
    Antimicrob Agents Chemother; 1987 Jan; 31(1):67-9. PubMed ID: 3566241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative study of therapeutic response of patients with clinical chancroid to ciprofloxacin, erythromycin, and cotrimoxazole.
    D'Souza P; Pandhi RK; Khanna N; Rattan A; Misra RS
    Sex Transm Dis; 1998 Jul; 25(6):293-5. PubMed ID: 9662762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chancroid: a review for the family practitioner.
    Jordan WC
    J Natl Med Assoc; 1991 Aug; 83(8):724-6. PubMed ID: 1956085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. European guideline for the management of chancroid, 2011.
    Kemp M; Christensen JJ; Lautenschlager S; Vall-Mayans M; Moi H
    Int J STD AIDS; 2011 May; 22(5):241-4. PubMed ID: 21571970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Presumptive specific clinical diagnosis of genital ulcer disease (GUD) in a primary health care setting in Nairobi.
    Ndinya-Achola JO; Kihara AN; Fisher LD; Krone MR; Plummer FA; Ronald A; Holmes KK
    Int J STD AIDS; 1996; 7(3):201-5. PubMed ID: 8799783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical evaluation of rosoxacin for the treatment of chancroid.
    Haase DA; Ndinya-Achola JO; Nash RA; D'Costa LJ; Hazlett D; Lubwama S; Nsanze H; Ronald AR
    Antimicrob Agents Chemother; 1986 Jul; 30(1):39-41. PubMed ID: 3489439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The management of resistant chancroid in Vietnam.
    Marmar JL
    J Urol; 1972 May; 107(5):807-8. PubMed ID: 4537134
    [No Abstract]   [Full Text] [Related]  

  • 51. Isolation of Haemophilus ducreyi from genital ulcerations in white men in Johannesburg.
    Mauff AC; Ballard RC; Bilgeri YR; Koornhof HJ
    S Afr Med J; 1983 Feb; 63(7):236-7. PubMed ID: 6600526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro activity of azithromycin and erythromycin against organisms associated with bacterial vaginosis and chancroid.
    Jones BM; Kinghorn GR; Duerden BI
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):551-3. PubMed ID: 3141171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and in situ cellular responses to Haemophilus ducreyi in the presence or absence of HIV infection.
    King R; Choudhri SH; Nasio J; Gough J; Nagelkerke NJ; Plummer FA; Ndinya-Achola JO; Ronald AR
    Int J STD AIDS; 1998 Sep; 9(9):531-6. PubMed ID: 9764937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
    Sanson-Le Pors MJ; Casin IM; Thebault MC; Arlet G; Perol Y
    Antimicrob Agents Chemother; 1986 Sep; 30(3):512-3. PubMed ID: 2946262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhoea (PPNG and non-PPNG infections): analysis of efficacy and patient preference.
    Panikabutra K; Lee CT; Ho B; Bamberg P
    Genitourin Med; 1988 Aug; 64(4):235-40. PubMed ID: 2971603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation of Haemophilus ducreyi from patients with chancroid in Auckland.
    Thorne GH; Say PJ; Hookham AB
    N Z Med J; 1982 Jun; 95(709):380-2. PubMed ID: 7050782
    [No Abstract]   [Full Text] [Related]  

  • 57. Short-course and single-dose antimicrobial therapy for chancroid in Kenya: studies with rifampin alone and in combination with trimethoprim.
    Plummer FA; Nsanze H; D'Costa LJ; Ndugga Maggwa AB; Girouard Y; Karasira P; Albritton WL; Ronald AR
    Rev Infect Dis; 1983; 5 Suppl 3():S565-72. PubMed ID: 6635447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Image of the month. Combined chancre, a soft chancroid and a syphilitic chancre].
    Henry F; Devillers C; Szepetiuk G; Piérard GE
    Rev Med Liege; 2009 Apr; 64(4):177-8. PubMed ID: 19514534
    [No Abstract]   [Full Text] [Related]  

  • 59. [Importance of culture media choice in the isolation of Haemophilus ducreyi. Experience in Senegal].
    Dieng Sarr A; Toure Kane NC; Samb ND; Boye CS; Diaw IK; Diouf G; N'Doye I; M'Boup S
    Bull Soc Pathol Exot; 1994; 87(1):22-7. PubMed ID: 8003900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Involuntary in vivo evidence for penicillin resistance of Streptobacillus haemophilus ducrey].
    Kuhlwein A; Konietzko D; Reinel D; Rohde BT
    Z Hautkr; 1980 May; 55(10):661-6. PubMed ID: 6967657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.